188P Impact of metformin, statin, aspirin and insulin on the prognosis of unresectable HCC patients receiving first-line lenvatinib or atezolizumab plus bevacizumab
M. Rimini, Elisabeth Amadeo, Francesco Vitiello, Silvia Foti, M. Persano, Toshifumi Tada, Goki Suda, S. Shimose, Masatoshi Kudo, Jaekyung Cheon, F. Finkelmeier, Ho Yeong Lim, F. Piscaglia, Gianluca Masi, Changhoon Yoo, S. Lonardi, Federico Rossari, Silvia Camera, A. Casadei Gardini, José Presa (2023). 188P Impact of metformin, statin, aspirin and insulin on the prognosis of unresectable HCC patients receiving first-line lenvatinib or atezolizumab plus bevacizumab. , 34, DOI: https://doi.org/10.1016/j.annonc.2023.10.767.
